Vaxcyte, Inc. PCVX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s short-term investments?
- Vaxcyte, Inc. (PCVX) reported short-term investments of $1.48B in Q1 2026.
- How has Vaxcyte, Inc.'s short-term investments changed year-over-year?
- Vaxcyte, Inc.'s short-term investments increased by 11.4% year-over-year, from $1.32B to $1.48B.
- What is the long-term trend for Vaxcyte, Inc.'s short-term investments?
- Over 4 years (2021 to 2025), Vaxcyte, Inc.'s short-term investments has grown at a 67.3% compound annual growth rate (CAGR), from $176.99M to $1.39B.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.